百克生物：近日收到《药品注册证书》

Group 1 - The core point of the article is that Baike Biological has received the Drug Registration Certificate for its nasal spray influenza attenuated live vaccine from the National Medical Products Administration [1] Group 2 - The announcement was made on the evening of August 25, indicating a significant regulatory milestone for the company [1] - The approval of the vaccine may enhance the company's product portfolio and market position in the biopharmaceutical industry [1] - This development reflects the ongoing efforts in the industry to innovate and provide effective vaccination options against influenza [1]